|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Aug―02 |
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies |
Emily G. Oakes, Eilish Dillon, Katherine A. Buhler, Hongshu Guan, Misti Paudel, Kathryne Marks, Ifeoluwakiisi Adejoorin, Jeong Yee, Jack Ellrodt, Sara Tedeschi, Jeffrey Sparks, Siobhan M. Case, Tiffany Hsu, Daniel H. Solomon, A. Helena Jonsson, Roberta Vezza Alexander, Deepak A. Rao, May Y. Choi, Karen H. Costenbader |
2 |
[GO] |
2024―Jun―26 |
Cellular pathways and molecular events that shape autoantibody production in COVID-19 |
Gregory J. Tsay, Moncef Zouali |
3 |
[GO] |
2024―May―25 |
Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndrome |
Suguru Saito, Shima Shahbaz, Mohammed Osman, Desiree Redmond, Najmeh Bozorgmehr, Rhonda J. Rosychuk, Grace Lam, Wendy Sligl, Jan Willem Cohen Tervaert, Shokrollah Elahi |
4 |
[GO] |
2024―Feb―21 |
mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses |
Jet van den Dijssel, Mariël C. Duurland, Veronique AL. Konijn, Laura YL. Kummer, Ruth R. Hagen, Lisan H. Kuijper, Luuk Wieske, Koos PJ. van Dam, Eileen W. Stalman, Maurice Steenhuis, Dionne M. Geerdes, Juk Yee Mok, Angela HM. Kragten, Charlotte Menage, Lianne Koets, Barbera Veldhuisen, Niels JM. Verstegen, C Ellen van der Schoot, Wim JE. van Esch, Geert RAM. D'Haens, Mark Löwenberg, Adriaan G. Volkers, Theo Rispens, Taco W. Kuijpers, Filip Eftimov, Klaas PJM. van Gisbergen, S Marieke van Ham, Anja ten Brinke, Carolien E. van de Sandt, Renée CF. van Allaart, Adája E. Baars, Marcel W. Bekkenk, Frederike J. Bemelman, Laura Boekel, Amélie V. Bos, Angela L. Bosma, Bo Broens, Esther Brusse, Matthias H. Busch, Olvi Cristianawati, Pieter A. van Doorn, George Elias, Cécile ACM. van Els, Marit J. van Gils, H Stephan Goedee, Dirk Jan Hijnen, Marc L. Hilhorst, Barbara Horváth, Papay BP. Jallah, Rivka de Jongh, Elham S. Mirfazeli, Annelie H. Musters, Jim BD. Keijser, Zoé LE. van Kempen, Joep Killestein, Christine Kreher, Karina de Leeuw, Anneke J. van der Kooi, Lotte van Ouwerkerk, Pieter van Paassen, Virginia Palomares Cabeza, Agner R. Parra Sanchez, W. Ludo van der Pol, Nicoline F. Post, Joop Raaphorst, Annabel M. Ruiter, Abraham Rutgers, Corine RG. Schreurs, Phyllis I. Spuls, R Bart Takkenberg, Sander W. Tas, YK Onno Teng, Yosta Vegting, Jan JGM. Verschuuren, Alexandre E. Voskuyl, Jelle de Wit, Gerrit J. Wolbink, Diane van der Woude, Koos AH. Zwinderman |
5 |
[GO] |
2023―Nov―11 |
Novel and unique rheumatoid factors cross-react with viral epitopes in COVID-19 |
Maya F. Amjadi, Maxwell H. Parker, Ryan R. Adyniec, Zihao Zheng, Alex M. Robbins, S. Janna Bashar, Michael F. Denny, Sara S. McCoy, Irene M. Ong, Miriam A. Shelef |
6 |
[GO] |
2023―Oct―10 |
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients |
Christa Lichtensteiger, Maximilian Koblischke, Fiamma Berner, Ann-Kristin Jochum, Tobias Sinnberg, Beatrice Balciunaite, Mette-Triin Purde, Vincent Walter, Marie-Therese Abdou, Kathrin Hofmeister, Philipp Kohler, Pietro Vernazza, Werner C. Albrich, Christian R. Kahlert, Alexander Zoufaly, Marianna T. Traugott, Lukas Kern, Urs Pietsch, Gian-Reto Kleger, Miodrag Filipovic, Manfred Kneilling, Antonio Cozzio, Oltin Pop, David Bomze, Andreas Bergthaler, Omar Hasan Ali, Judith Aberle, Lukas Flatz |
7 |
[GO] |
2023―Jun―12 |
Molecular mimicry and autoimmunity in the time of COVID-19 |
Manuel Rojas, María Herrán, Carolina Ramírez-Santana, Patrick S.C. Leung, Juan Manuel-Anaya, William M. Ridgway, M. Eric Gershwin |
8 |
[GO] |
2023―Jun―12 |
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study |
Renske G Kamperman, Ester Mm van Leeuwen, Myrthe Willems, Anneke J van der Kooi, Kyra A Gelderman, Dörte Hamann, Ellen G van Lochem, Bob Meek, Renate G van der Molen, Anouk Cm Platteel, Henny G Otten, Marco Wj Schreurs, Joost Raaphorst |
9 |
[GO] |
2023―May―15 |
Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines |
Chuang-Wei Wang, Chun-Bing Chen, Chun-Wei Lu, Wei-Ti Chen, Rosaline Chung-Yee Hui, Tsu-Man Chiu, Min-Hui Chi, Jing-Chi Lin, Yu-Huei Huang, Ya-Ching Chang, Jennifer Wu, Kuan-Yu Chen, Yang Yu-Wei Lin, Tzong-Yun Ger, Jing Yi Lin, Wan-Ting Tsai, Yen-Ju Pan, Wen-Hung Chung |
10 |
[GO] |
2023―Mar―02 |
Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases |
Raffaella Greco, John A. Snowden, Nina Simone Knelange, Gloria Tridello, Carlotta Cacciatore, Alienor Xhaard, Fabio Ciceri, Matthew Collin, Christelle Ferra, Ann De Becker, Dina Averbuch, Tobias Alexander, Per Ljungman, Rafael De la Camara |
11 |
[GO] |
2023―Jan―09 |
Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non-to low-responders and B cell deficient rheumatic disease patients |
Alexander ten Hagen, Sandra Hermann, Elisa Habermann, Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Veronika Scholz, Khetam Ghannam, Jens Klotsche, Jan Zernicke, Tobias Alexander, Gerd-R. Burmester, Fredrik N. Albach, Robert Biesen |
12 |
[GO] |
2023―Jan―06 |
Pre-existing conditions associated with post-acute sequelae of COVID-19 |
Elizabeth T. Jacobs, Collin J. Catalfamo, Paulina M. Colombo, Sana M. Khan, Erika Austhof, Felina Cordova-Marks, Kacey C. Ernst, Leslie V. Farland, Kristen Pogreba-Brown |
13 |
[GO] |
2023―Jan―02 |
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations |
Koos P.J. van Dam, Luuk Wieske, Eileen W. Stalman, Laura Y.L. Kummer, Jesse Roosen, Zoé L.E. van Kempen, Joep Killestein, Adriaan G. Volkers, Laura Boekel, Gerrit J. Wolbink, Anneke J. van der Kooi, Joost Raaphorst, Mark Löwenberg, R. Bart Takkenberg, Geert R.A.M. D'Haens, Phyllis I. Spuls, Marcel W. Bekkenk, Annelie H. Musters, Nicoline F. Post, Angela L. Bosma, Marc L. Hilhorst, Yosta Vegting, Frederike J. Bemelman, Alexandre E. Voskuyl, Bo Broens, Agner Parra Sanchez, Cécile A.C.M. van Els, Jelle de Wit, Abraham Rutgers, Karina de Leeuw, Barbara Horváth, Jan J.G.M. Verschuuren, Annabel M. Ruiter, Lotte van Ouwerkerk, Diane van der Woude, Renée C.F. Allaart, Y.K. Onno Teng, Pieter van Paassen, Matthias H. Busch, Papay B.P. Jallah, Esther Brusse, Pieter A. van Doorn, Adája E. Baars, Dirk Jan Hijnen, Corine R.G. Schreurs, W.Ludo van der Pol, H. Stephan Goedee, Maurice Steenhuis, Sofie Keijzer, Jim B.D. Keijser, Olvi Cristianawati, Theo Rispens, Anja ten Brinke, Niels J.M. Verstegen, S. Marieke van Ham, Sander W. Tas, Taco W. Kuijpers, Filip Eftimov |
14 |
[GO] |
2022―Dec―22 |
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases |
Daniel Mrak, Felix Kartnig, Daniela Sieghart, Elisabeth Simader, Helga Radner, Peter Mandl, Lisa Göschl, Philipp Hofer, Thomas Deimel, Irina Gessl, Renate Kain, Stefan Winkler, Josef S. Smolen, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha, Leonhard X. Heinz, Michael Bonelli |
15 |
[GO] |
2022―Dec―16 |
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination |
Pascale Palassin, Virginie Bres, Samaher Hassan, Ange Alfonsi, Nathalie Massy, Valérie Gras-Champel, Alexandre Thibault Jacques Maria, Jean-Luc Faillie |
16 |
[GO] |
2022―Nov―29 |
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus national vaccine registry for ImmuNe diseases Singapore (CONVIN-SING) |
Margaret Ma, Amelia Santosa, Warren Fong, C.H.E.W. Li-Ching, Andrea Hl Low, Annie Law, Yih Jia Poh, Siaw Ing Yeo, Ying Ying Leung, Victoria Ww Ng, Joshua Ze Koh, Sen Hee Tay, M.A.K. Anselm, Gim Gee Teng, Chuanhui Xu, Johnston Gx Tang, Kok Ooi Kong, Stanley Angkodjojo, Wei-Rui Goh, Tyng Yu Chuah, Nur Emillia Roslan, Thaschawee Arkachaisri, Kai Liang Teh, Melonie Sriranganathan, Teck Choon Tan, Kee Fong Phang, Qai Ven Yap, Yiong Huak Chan, Peter Pm Cheung, Manjari Lahiri |
17 |
[GO] |
2022―Nov―11 |
On the peptide binding affinity changes in population-specific HLA repertoires to the SARS-CoV-2 variants Delta and Omicron |
Lu-Chun Chen, Stepan Nersisyan, Chang-Jiun Wu, Che-Mai Chang, Alexander Tonevitsky, Chin-Lin Guo, Wei-Chiao Chang |
18 |
[GO] |
2022―Oct―11 |
Induction of cross-reactive, mucosal anti-SARS-CoV-2 antibody responses in rheumatoid arthritis patients after 3rd dose of COVID-19 vaccination |
M. Bondareva, P. Letz, K. Karberg, E. Schrezenmeier, I. Semin, H. Rincon-Arevalo, T. Dörner, M.F. Mashreghi, A.-L. Stefanski, A.A. Kruglov |
19 |
[GO] |
2022―Oct―04 |
Risk for uveitis relapse after COVID-19 vaccination |
Zhenyu Zhong, Qiuying Wu, Yuxian Lai, Lingyu Dai, Yu Gao, Weiting Liao, Xiaojie Feng, Peizeng Yang |
20 |
[GO] |
2022―Sep―20 |
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity? |
Hiroki Hosoi, Misato Tane, Hideki Kosako, Masaki Ibe, Masahiro Takeyama, Shogo Murata, Toshiki Mushino, Takashi Sonoki |
21 |
[GO] |
2022―Sep―12 |
Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases |
Yves Renaudineau, Laurent Sailler, Florence Abravanel, Jacques Izopet, Adrien Delourme, Damien Biotti, Jonathan Ciron, Emmanuel Treiner, Nicolas Congy-Jolivet, Chloé Bost, Antoine Blancher |
22 |
[GO] |
2022―Sep―07 |
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis |
Cumali Efe, Koray Taşçılar, Alessio Gerussi, Francesca Bolis, Craig Lammert, Berat Ebik, Albert Friedrich Stättermayer, Mustafa Cengiz, Dilara Turan Gökçe, Laura Cristoferi, Mirta Peralta, Hatef Massoumi, Pedro Montes, Eira Cerda, Cristina Rigamonti, Suna Yapalı, Gupse Adali, Ali Rıza Çalışkan, Yasemin Balaban, Fatih Eren, Tuğçe Eşkazan, Sezgin Barutçu, Ellina Lytvyak, Godolfino Miranda Zazueta, Meral Akdogan Kayhan, Alexandra Heurgue-Berlot, Eleonora De Martin, Ahmet Yavuz, Murat Bıyık, Graciela Castro Narro, Serkan Duman, Nelia Hernandez, Nikolaos K. Gatselis, Jonathan Aguirre, Ramazan Idilman, Marcelo Silva, Manuel Mendizabal, Kadri Atay, Fatih Güzelbulut, Renumathy Dhanasekaran, Aldo J. Montano-Loza, George N. Dalekos, Ezequiel Ridruejo, Pietro Invernizzi, Staffan Wahlin |
23 |
[GO] |
2022―Aug―24 |
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review |
Yhojan Rodríguez, Manuel Rojas, Santiago Beltrán, Fernando Polo, Laura Camacho-Domínguez, Samuel David Morales, M. Eric Gershwin, Juan-Manuel Anaya |
24 |
[GO] |
2022―Aug―22 |
IgA-diseases associated to SARS-CoV-2 infection or vaccination: A systematic literature review |
Gabriel Bronz, Pietro B. Faré, Sebastiano A.G. Lava, Mario G. Bianchetti, Giacomo D. Simonetti, Martin Scoglio, Benedetta Terziroli Beretta-Piccoli, Carlo Agostoni, Gregorio P. Milani |
25 |
[GO] |
2022―Aug―18 |
COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman |
Wangbin Ning, Wanli Xu, Xiaomei Cong, Hongkuan Fan, Gary Gilkeson, Xueling Wu, Heather Hughes, Wei Jiang |
26 |
[GO] |
2022―Aug―05 |
Autoimmune hepatitis following COVID-19 vaccination |
Arantzazu Izagirre, Teresa Arzallus, Maddi Garmendia, Silvia Torrente, Agustin Castiella, Eva María Zapata |
27 |
[GO] |
2022―Jul―20 |
COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study |
Matheus Vieira, Cloé Comarmond, Julien Labreuche, Adrien Mirouse, David Saadoun, Christophe Richez, René-Marc Flipo, Eric Hachulla, Elodie Drumez, Patrice Cacoub |
28 |
[GO] |
2022―Jul―11 |
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases |
Clodoveo Ferri, Laura Gragnani, Vincenzo Raimondo, Marcella Visentini, Dilia Giuggioli, Serena Lorini, Rosario Foti, Fabio Cacciapaglia, Maurizio Caminiti, Domenico Olivo, Giovanna Cuomo, Roberta Pellegrini, Erika Pigatto, Teresa Urraro, Caterina Naclerio, Antonio Tavoni, Lorenzo Puccetti, Ilaria Cavazzana, Piero Ruscitti, Marta Vadacca, Francesca La Gualana, Franco Cozzi, Amelia Spinella, Elisa Visalli, Ylenia Dal Bosco, Giorgio Amato, Francesco Masini, Giuseppa Pagano Mariano, Raffaele Brittelli, Vincenzo Aiello, Daniela Scorpiniti, Giovanni Rechichi, Giuseppe Varcasia, Monica Monti, Giusy Elia, Franco Franceschini, Milvia Casato, Francesco Ursini, Roberto Giacomelli, Poupak Fallahi, Stefano Angelo Santini, Florenzo Iannone, Carlo Salvarani, Anna Linda Zignego, Alessandro Antonelli |
29 |
[GO] |
2022―Jun―13 |
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy |
Davide Firinu, Giuseppe Fenu, Giuseppina Sanna, Giulia A. Costanzo, Andrea Perra, Marcello Campagna, Roberto Littera, Carlotta Locci, Alessandra Marongiu, Riccardo Cappai, Maurizio Melis, Germano Orré, Stefano Del Giacco, Ferdinando Coghe, Aldo Manzin, Luchino Chessa |
30 |
[GO] |
2022―Jun―09 |
COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases |
Athanasios-Dimitrios Bakasis, Clio P. Mavragani, Paraskevi V. Voulgari, Nafsika Gerolymatou, Ourania D. Argyropoulou, Panayiotis G. Vlachoyiannopoulos, Fotini N. Skopouli, Athanasios G. Tzioufas, Haralampos M. Moutsopoulos |
31 |
[GO] |
2022―Apr―14 |
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong |
Xue Li, Le Gao, Xinning Tong, Vivien K.Y. Chan, Celine S.L. Chui, Francisco T.T. Lai, Carlos K.H. Wong, Eric Y.F. Wan, Esther W.Y. Chan, Kui Kai Lau, Chak Sing Lau, Ian C.K. Wong |
32 |
[GO] |
2022―Apr―11 |
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients |
Martina Fabris, Ginevra De Marchi, Rossana Domenis, Federica Caponnetto, Silvia Guella, Chiara Dal Secco, Nicola Cabas, Salvatore De Vita, Antonio Paolo Beltrami, Francesco Curcio, Luca Quartuccio |
33 |
[GO] |
2022―Feb―24 |
Relapsed and newly diagnosed Graves’ disease due to immunization against COVID-19: A case series and review of the literature |
Hayri Bostan, Bekir Ucan, Muhammed Kizilgul, Murat Calapkulu, Sema Hepsen, Umran Gul, Ilknur Ozturk Unsal, Erman Cakal |
34 |
[GO] |
2022―Jan―01 |
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy |
Azizul Haque, Anudeep B. Pant |
35 |
[GO] |
2021―Dec―28 |
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination |
G. Fiorillo, S. Pancetti, A. Cortese, F. Toso, S. Manara, A. Costanzo, R.G. Borroni |
36 |
[GO] |
2021―Dec―14 |
Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence? |
Shotaro Tabata, Hiroki Hosoi, Shogo Murata, Satomi Takeda, Toshiki Mushino, Takashi Sonoki |
37 |
[GO] |
2021―Dec―13 |
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies |
Saathvik R. Kannan, Austin N. Spratt, Kalicharan Sharma, Hitendra S. Chand, Siddappa N. Byrareddy, Kamal Singh |
38 |
[GO] |
2021―Dec―06 |
Ferritin - from iron, through inflammation and autoimmunity, to COVID-19 |
Naim Mahroum, Amal Alghory, Zeynep Kiyak, Abdulkarim Alwani, Ravend Seida, Mahmoud Alrais, Yehuda Shoenfeld |
39 |
[GO] |
2021―Nov―11 |
Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up? |
Enver Avci, Fatma Abasiyanik |
40 |
[GO] |
2021―Nov―10 |
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups |
Clodoveo Ferri, Francesco Ursini, Laura Gragnani, Vincenzo Raimondo, Dilia Giuggioli, Rosario Foti, Maurizio Caminiti, Domenico Olivo, Giovanna Cuomo, Marcella Visentini, Fabio Cacciapaglia, Roberta Pellegrini, Erika Pigatto, Teresa Urraro, Caterina Naclerio, Antonio Tavoni, Lorenzo Puccetti, Giuseppe Varcasia, Ilaria Cavazzana, Massimo L'Andolina, Piero Ruscitti, Marta Vadacca, Pietro Gigliotti, Francesca La Gualana, Franco Cozzi, Amelia Spinella, Elisa Visalli, Ylenia Dal Bosco, Giorgio Amato, Francesco Masini, Giuseppa Pagano Mariano, Raffaele Brittelli, Vincenzo Aiello, Rodolfo Caminiti, Daniela Scorpiniti, Giovanni Rechichi, Tommaso Ferrari, Monica Monti, Giusy Elia, Franco Franceschini, Riccardo Meliconi, Milvia Casato, Florenzo Iannone, Roberto Giacomelli, Poupak Fallahi, Stefano Angelo Santini, Anna Linda Zignego, Alessandro Antonelli |
41 |
[GO] |
2021―Oct―28 |
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases |
Athanasios G. Tzioufas, Athanasios-Dimitrios Bakasis, Andreas V. Goules, Kleopatra Bitzogli, Ilir I. Cinoku, Loukas G. Chatzis, Ourania D. Argyropoulou, Aliki I. Venetsanopoulou, Maria Mavrommati, Ioanna E. Stergiou, Vasilis Pezoulas, Paraskevi V. Voulgari, Chaido Katsimpari, Spyridon Katechis, Souzana Gazi, Gkikas Katsifis, Charalampos I. Sfontouris, Athanasios I. Georgountzos, Stamatis-Nick Liossis, Charalampos Papagoras, Dimitrios I. Fotiadis, Fotini N. Skopouli, Panayiotis G. Vlachoyiannopoulos, Haralampos M. Moutsopoulos |
42 |
[GO] |
2021―Oct―28 |
Post COVID-19 hospitalizations in patients with chronic inflammatory diseases - A nationwide cohort study |
Bente Mertz Nørgård, Floor Dijkstra Zegers, Jan Nielsen, Jens Kjeldsen |
43 |
[GO] |
2021―Oct―27 |
Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence |
Isabel Garrido, Susana Lopes, Manuel Sobrinho Simões, Rodrigo Liberal, Joanne Lopes, Fátima Carneiro, Guilherme Macedo |
44 |
[GO] |
2021―Oct―26 |
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data |
Luigi Cari, Mahdieh Naghavi Alhosseini, Paolo Fiore, Sabata Pierno, Sabrina Pacor, Alberta Bergamo, Gianni Sava, Giuseppe Nocentini |
45 |
[GO] |
2021―Oct―13 |
A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination |
Armando Patrizio, Silvia Martina Ferrari, Alessandro Antonelli, Poupak Fallahi |
46 |
[GO] |
2021―Oct―12 |
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network |
Rahul Raiker, Haig Pakhchanian, Charles DeYoung, Latika Gupta, Sinan Kardeş, Sakir Ahmed, Chengappa Kavadichanda |
47 |
[GO] |
2021―Sep―27 |
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination |
Massimo Cugno, Paolo Macor, Mara Giordano, Marcello Manfredi, Samantha Griffini, Elena Grovetti, Luca De Maso, Simona Mellone, Luca Valenti, Daniele Prati, Sara Bonato, Giacomo Comi, Andrea Artoni, Pier Luigi Meroni, Flora Peyvandi |
48 |
[GO] |
2021―Aug―11 |
Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses |
Saathvik R. Kannan, Austin N. Spratt, Alisha R. Cohen, S. Hasan Naqvi, Hitendra S. Chand, Thomas P. Quinn, Christian L. Lorson, Siddappa N. Byrareddy, Kamal Singh |
49 |
[GO] |
2021―Jul―28 |
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination |
Élise Vuille-Lessard, Matteo Montani, Jaume Bosch, Nasser Semmo |
50 |
[GO] |
2021―Jul―27 |
Thrombocytopenia after COVID-19 vaccination |
Kristian Kragholm, Maurizio Sessa, Thomas Mulvad, Mikkel Porsborg Andersen, Helle Collatz-Christensen, Stig Nikolaj Blomberg, Freddy Lippert, Soren Mikkelsen, Peter Leutscher, Dorte Melgaard, Christian Torp-Pedersen, Soren Risom Kristensen, Torben Bjerregaard Larsen, Peter Sogaard |
51 |
[GO] |
2021―Jul―20 |
Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study |
Mar Masiá, Marta Fernández-González, Guillermo Telenti, Vanesa Agulló, José A. García, Sergio Padilla, Javier García-Abellán, Antonio Galiana, Nieves Gonzalo-Jiménez, Félix Gutiérrez |
52 |
[GO] |
2021―Jul―16 |
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review |
Athanasios-Dimitrios Bakasis, Clio P. Mavragani, Kyriaki A. Boki, Athanasios G. Tzioufas, Panayiotis G. Vlachoyiannopoulos, Ioanna E. Stergiou, Fotini N. Skopouli, Haralampos M. Moutsopoulos |
53 |
[GO] |
2021―Jul―15 |
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity? |
Michele Ghielmetti, Helen Dorothea Schaufelberger, Giorgina Mieli-Vergani, Andreas Cerny, Eric Dayer, Diego Vergani, Benedetta Terziroli Beretta-Piccoli |
54 |
[GO] |
2021―Jun―23 |
Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data |
Luigi Cari, Paolo Fiore, Mahdieh Naghavi Alhosseini, Gianni Sava, Giuseppe Nocentini |
55 |
[GO] |
2021―Jun―21 |
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals |
Holger Lingel, Stefan Meltendorf, Ulrike Billing, Christoph Thurm, Katrin Vogel, Christiane Majer, Florian Prätsch, Dirk Roggenbuck, Hans-Gert Heuft, Thomas Hachenberg, Eugen Feist, Dirk Reinhold, Monika C. Brunner-Weinzierl |
56 |
[GO] |
2021―Jun―15 |
Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines |
Jimin Hwang, Se Bee Lee, Seung Won Lee, Min Ho Lee, Ai Koyanagi, Louis Jacob, Kalthoum Tizaoui, Dong Keon Yon, Jae Il Shin, Lee Smith |
57 |
[GO] |
2021―Jun―11 |
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19 |
Ana I. Rodriguez-Perez, Carmen M. Labandeira, Maria A. Pedrosa, Rita Valenzuela, Juan A. Suarez-Quintanilla, María Cortes-Ayaso, Placido Mayán-Conesa, Jose L. Labandeira-Garcia |
58 |
[GO] |
2021―May―19 |
Differences in venous immunothrombosis in severe COVID-19 pneumonia and Vaccine-Induced Thrombotic Thrombocytopenia (VITT) - It's in the viral DNA |
Dennis McGonagle, Gabriele De Marco, Charles Bridgewood |
59 |
[GO] |
2021―May―01 |
A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine |
Haralampos M. Moutsopoulos |
60 |
[GO] |
2021―Apr―30 |
Corrigendum to “Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19” [J. Autoimmun. 117C (2020) 102595] |
Luca Valenti, Samantha Griffini, Giuseppe Lamorte, Elena Grovetti, Sara Colonia Uceda Renteria, Francesco Malvestiti, Luigia Scudeller, Alessandra Bandera, Flora Peyvandi, Daniele Prati, Pierluigi Meroni, Massimo Cugno |
61 |
[GO] |
2021―Apr―27 |
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19 |
Julia Y. Wang, Wei Zhang, Michael W. Roehrl, Victor B. Roehrl, Michael H. Roehrl |
62 |
[GO] |
2021―Mar―26 |
Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark |
Jens Kjeldsen, Jan Nielsen, Torkell Ellingsen, Torben Knudsen, Rasmus Gaardskær Nielsen, Michael Due Larsen, Ken Lund, Bente Mertz Nørgård |
63 |
[GO] |
2021―Feb―15 |
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies - A Danish population-based cohort study |
Mohamed Attauabi, Jakob Benedict Seidelin, Oluf Krautwald Felding, Mads Damsgaard Wewer, Laura Kirstine Vinther Arp, Melek Zahra Sarikaya, Alexander Egeberg, Nora Vladimirova, Flemming Bendtsen, Johan Burisch |
64 |
[GO] |
2021―Jan―22 |
COVID-19 convalescent plasma composition and immunological effects in severe patients |
Yeny Acosta-Ampudia, Diana M. Monsalve, Manuel Rojas, Yhojan Rodríguez, Juan Esteban Gallo, Juan Carlos Salazar-Uribe, María José Santander, Mónica P. Cala, Wildeman Zapata, María Isabel Zapata, Rubén Manrique, Juan Mauricio Pardo-Oviedo, Bernardo Camacho, Carolina Ramírez-Santana, Juan-Manuel Anaya |
65 |
[GO] |
2021―Jan―15 |
Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status |
Yonggang Zhou, Jinhe Zhang, Dongyao Wang, Dong Wang, Wuxiang Guan, Jingkun Qin, Xiuxiu Xu, Jingwen Fang, Binqing Fu, Xiaohu Zheng, Dongsheng Wang, Hong Zhao, Xianxiang Chen, Zhigang Tian, Xiaoling Xu, Guiqiang Wang, Haiming Wei |
66 |
[GO] |
2021―Jan―12 |
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19 |
Luca Valenti, Samantha Griffini, Giuseppe Lamorte, Elena Grovetti, Sara Colonia Uceda Renteria, Francesco Malvestiti, Luigia Scudeller, Alessandra Bandera, Flora Peyvandi, Daniele Prati, Pierluigi Meroni, Massimo Cugno |
67 |
[GO] |
2020―Dec―16 |
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature |
Lucia Novelli, Francesca Motta, Maria De Santis, Aftab A. Ansari, M. Eric Gershwin, Carlo Selmi |
68 |
[GO] |
2020―Nov―30 |
A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center |
Juan C. Sarmiento-Monroy, Gerard Espinosa, Maria-Carlota Londoño, Fernanda Meira, Berta Caballol, Sara Llufriu, Josep Lluis Carrasco, Aina Moll-Udina, Luis F. Quintana, Priscila Giavedoni, Julio Ramírez, Jose Inciarte-Mundo, Elisabeth Solana, Yolanda Blanco, Eugenia Martinez-Hernandez, Maria Sepúlveda, Victor Llorenç, Sergio Prieto-González, Georgina Espígol-Frigolé, Jose C. Milisenda, Maria C. Cid, Jose M. Mascaró, Isabel Blanco, Joan Albert Barberá, Oriol Sibila, Jordi Gratacos-Ginès, Alfredo Adán, Alvaro Agustí, Raimon Sanmartí, Julian Panés, Ricard Cervera, Jordi Vila, Alex Soriano, José A. Gómez-Puerta |
69 |
[GO] |
2020―Oct―30 |
Complement activation and endothelial perturbation parallel COVID-19 severity and activity |
Massimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, Samantha Griffini, Elena Grovetti, Adriana Torri, Paola Lonati, Claudia Grossi, Maria Orietta Borghi, Cristina Novembrino, Massimo Boscolo, Sara Colonia Uceda Renteria, Luca Valenti, Giuseppe Lamorte, Maria Manunta, Daniele Prati, Antonio Pesenti, Francesco Blasi, Giorgio Costantino, Andrea Gori, Alessandra Bandera, Francesco Tedesco, Flora Peyvandi |
70 |
[GO] |
2020―Aug―20 |
High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients |
Enrique Iglesias Julián, María López Veloso, Noelia de la Torre Ferrera, Julio Cesar Barraza Vengoechea, Pedro David Delgado-López, María Colazo Burlato, Marta Ubeira Iglesias, Miguel Montero Baladía, Andrés Lorenzo Martín, Javier Minguito de la Iglesia, Juan Pablo García Muñoz, Rodrigo Sanllorente Sebastián, Blanca Vicente González, Ana Alemán Alemán, Luis Buzón Martín |
71 |
[GO] |
2020―Jul―16 |
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study |
Oscar Moreno-Pérez, Mariano Andres, Jose-Manuel Leon-Ramirez, José Sánchez-Payá, Juan Carlos Rodríguez, Rosario Sánchez, Raquel García-Sevila, Vicente Boix, Joan Gil, Esperanza Merino |
72 |
[GO] |
2020―Jul―08 |
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients |
Lorenzo M. Canziani, Serena Trovati, Enrico Brunetta, Amidio Testa, Maria De Santis, Emilio Bombardieri, Giacomo Guidelli, Giovanni Albano, Marco Folci, Michela Squadroni, Giordano D. Beretta, Michele Ciccarelli, Massimo Castoldi, Ana Lleo, Alessio Aghemo, Laura Vernile, Alberto Malesci, Paolo Omodei, Claudio Angelini, Salvatore Badalamenti, Maurizio Cecconi, Alberto Cremonesi, Carlo Selmi |
73 |
[GO] |
2020―Jul―03 |
Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab |
Austin R. Morrison, Joseph M. Johnson, Kristin M. Griebe, Mathew C. Jones, John J. Stine, Laura N. Hencken, Long To, Monica L. Bianchini, Amit T. Vahia, Jennifer Swiderek, Mayur S. Ramesh, Michael A. Peters, Zachary R. Smith |
74 |
[GO] |
2020―Jun―16 |
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 |
Yhojan Rodríguez, Lucia Novelli, Manuel Rojas, Maria De Santis, Yeny Acosta-Ampudia, Diana M. Monsalve, Carolina Ramírez-Santana, Antonio Costanzo, William M. Ridgway, Aftab A. Ansari, M. Eric Gershwin, Carlo Selmi, Juan-Manuel Anaya |
75 |
[GO] |
2020―Jun―08 |
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients |
M. Zen, E. Fuzzi, D. Astorri, F. Saccon, R. Padoan, L. Ienna, G. Cozzi, R. Depascale, E. Zanatta, M. Gasparotto, F. Benvenuti, S. Bindoli, M. Gatto, M. Felicetti, A. Ortolan, D. Campaniello, M. Larosa, M. Lorenzin, R. Ramonda, P. Sfriso, F. Schiavon, L. Iaccarino, A. Doria |
76 |
[GO] |
2020―May―16 |
Corrigendum to “The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China” [J. Autoimmun. 109C (2020) 102434] |
Yongshi Yang, Fujun Peng, Runsheng Wang, Ming Yang, Kai Guan, Taijiao Jiang, Guogang Xu, Jinlyu Sun, Christopher Chang |
77 |
[GO] |
2020―Apr―24 |
Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience |
Ying Sun, Yanli Dong, Lifeng Wang, Huan Xie, Baosen Li, Christopher Chang, Fu-sheng Wang |
78 |
[GO] |
2020―Apr―17 |
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 |
Carlo Perricone, Paola Triggianese, Elena Bartoloni, Giacomo Cafaro, Angelo F. Bonifacio, Roberto Bursi, Roberto Perricone, Roberto Gerli |
79 |
[GO] |
2020―Apr―13 |
Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19 |
Guoping Li, Xiang He, Lei Zhang, Qin Ran, Junyi Wang, Anying Xiong, Dehong Wu, Feng Chen, Jinlyu Sun, Christopher Chang |
80 |
[GO] |
2020―Apr―10 |
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? |
Bingwen Liu, Min Li, Zhiguang Zhou, Xuan Guan, Yufei Xiang |
81 |
[GO] |
2020―Apr―02 |
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |
Angela Ceribelli, Francesca Motta, Maria De Santis, Aftab A. Ansari, William M. Ridgway, M. Eric Gershwin, Carlo Selmi |
82 |
[GO] |
2020―Mar―03 |
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China |
Yongshi Yang, Fujun Peng, Runsheng Wang, Kai Guan, Taijiao Jiang, Guogang Xu, Jinlyu Sun, Christopher Chang |
83 |
[GO] |
2020―Feb―26 |
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak |
Hussin A. Rothan, Siddappa N. Byrareddy |
|